Publications by authors named "L D Gold"

Various interventions, including caregiver education, psychoeducation, teacher and clinician training and behavioral management embedded with education, are available to enhance awareness and knowledge among caregivers, teachers, and clinicians. This review synthesizes evidence on the effectiveness and cost-effectiveness of interventions to increase ADHD awareness and knowledge for caregivers, clinicians, and teachers. Peer-reviewed literature was identified through the systematic searches of six databases: MEDLINE Complete, APA PsycInfo, CINAHL Complete, ERIC, Global Health and EconLit.

View Article and Find Full Text PDF

Tapinarof cream 1% once daily (QD) demonstrated significant efficacy in patients down to age 2 years with atopic dermatitis (AD) in the ADORING 1 and 2 phase 3 trials. We report local tolerability outcomes. Patients received Tapinarof or vehicle cream QD for 8 weeks.

View Article and Find Full Text PDF

Introduction: Traumatic injury is the leading cause of pediatric mortality and morbidity in the United States. While behavioral impairments of children after traumatic brain injury (TBI) have been described, outcomes following traumatic spinal cord injury (SCI) and multi-trauma (MT) are less known. We aimed to address the prevalence of behavioral and neuropsychiatric disorders in pediatric and adolescent trauma patients.

View Article and Find Full Text PDF

Background: Psoriasis is a chronic inflammatory skin disease often associated with obesity. Psoriasis therapies may be less effective in patients with obese. The purpose of this expert consensus panel is to evaluate the relationship between obesity and efficacy of psoriasis therapies, thereby optimizing patient care.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of using gabapentin alongside opioids compared to tricyclic antidepressants (TCAs) or duloxetine with opioids in older adults with spine-related issues.
  • Researchers analyzed data from 134,266 Medicare beneficiaries, focusing on mortality rates and major medical complications from 2017 to 2019.
  • They found no significant difference in mortality between the two groups, but those on gabapentin and opioids had a slightly higher risk of major medical complications.
View Article and Find Full Text PDF